Cardiac safety of lacosamide: the non-clinical perspective
Authors:
- 21 April 2015
- journal article
- research article
- Published by Wiley in Acta Neurologica Scandinavica
- Vol. 132 (5) , 337-345
Abstract
Lacosamide is indicated for the adjunctive treatment of partial-onset seizures in adult patients. Unlike other sodium channel-blocking antiepileptic drugs, lacosamide selectively enhances sodium channel slow inactivation. Potential effects of lacosamide on cardiac sodium channels and their cardiovascular consequences were comprehensively assessed. This manuscript presents the non-clinical cardiac safety profile of lacosamide. Lacosamide was tested in vitro on sodium and L-type calcium currents from isolated human atrial myocytes and on hERG-mediated potassium currents from stably transfected HEK293 cells. Cardiac action potentials were recorded in guinea pig ventricular myocytes. In vivo, hemodynamic and ECG parameters were evaluated in anesthetized dogs and monkeys receiving acute cumulative intravenous doses of lacosamide. Following intravenous dosing with lacosamide, dose-dependent PR and QRS prolongation and ECG abnormalities (loss of P waves, atrioventricular and intraventricular blocks, junctional premature contractions) were observed in anesthetized dogs and monkeys. In vitro, lacosamide reduced human cardiac sodium currents in a concentration-, voltage- and state-dependent manner. Lacosamide reductions in Vmax in guinea pig myocytes were similar to lamotrigine and carbamazepine. Lacosamide showed no relevant inhibitory effects on hERG and L-type calcium channels and did not prolong QTc in vivo. ECG findings in anesthetized animals correlate well with in vitro sodium channel-related effects and are also consistent with those (PR prolongation, first-degree atrioventricular block) reported in healthy volunteers and patients with epilepsy. Both in vivo and in vitro effects were detected from exposure levels 1.5- to 2-fold above those achieved with the maximum-recommended human lacosamide dose (400 mg/day).Keywords
This publication has 22 references indexed in Scilit:
- Effect of lamotrigine on the PR interval in healthy subjectsBritish Journal of Clinical Pharmacology, 2011
- On the relationship between block of the cardiac Na+channel and drug-induced prolongation of the QRS complexBritish Journal of Pharmacology, 2011
- Cardiac ion channels in health and diseaseHeart Rhythm, 2010
- Cardiac Ion ChannelsCirculation: Arrhythmia and Electrophysiology, 2009
- The Investigational Anticonvulsant Lacosamide Selectively Enhances Slow Inactivation of Voltage-Gated Sodium ChannelsMolecular Pharmacology, 2008
- Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsyEpilepsy Research, 2007
- Preclinical Cardiovascular Risk Assessment in Modern Drug DevelopmentToxicological Sciences, 2007
- Lacosamide: A Review of Preclinical PropertiesCNS Drug Reviews, 2007
- Effects of the Novel Antiepileptic Drug Lacosamide on the Development of Amygdala Kindling in RatsEpilepsia, 2006
- Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei HerzkrankenActa Medica Scandinavica, 1920